The addition of radiofrequency ablation for patients receiving sorafenib: new evidence for a new standard?
Ann Transl Med
.
2021 Jan;9(1):3.
doi: 10.21037/atm-20-7474.
Authors
Michael Lock
1
,
Brandon M Meyers
2
,
Amol Mujoomdar
1
Affiliations
1
Western University, London, Ontario, Canada.
2
McMaster University, Hamilton, Ontario, Canada.
PMID:
33553296
PMCID:
PMC7859796
DOI:
10.21037/atm-20-7474
No abstract available
Publication types
Editorial
Comment